Connect with us

Business

Hyundai Motor India’s Q3 profit rises 6.3% to Rs 1,234 crore

Published

on

Hyundai Motor India’s Q3 profit rises 6.3% to Rs 1,234 crore


Mumbai: Hyundai Motor India Limited on Monday reported a solid performance in the third quarter (Q3) of FY26, with its consolidated net profit rising 6.3 per cent year-on-year to Rs 1,234.4 crore. The growth was supported by steady demand in the domestic market, strong export numbers and higher sales during the festive season, the company said in its stock exchange filing.

Revenue from operations during the quarter increased 8 percent compared to last year to Rs 17,973.5 crore. Operating performance also improved, with EBITDA rising 7.6 percent year-on-year to Rs 2,018.3 crore. The EBITDA margin stood at 11.2 percent, remaining broadly stable compared to the same period last financial year.

The company said domestic demand during the quarter benefited from GST 2.0-related advantages and festive-season momentum.

Add Zee News as a Preferred Source


Wholesale volumes rose 5 per cent sequentially, supported by strong retail sales across key models.

Exports played an important role in overall growth, with export volumes jumping 21 per cent year-on-year in the December quarter.

Exports contributed around 25 per cent to Hyundai Motor India’s total sales during the period.

On the product front, the Creta once again emerged as a key growth driver. The SUV reclaimed its position as India’s best-selling SUV and achieved its highest-ever annual sales of more than 2 lakh units in calendar year 2025.

The newly launched Venue also saw healthy demand, with nearly 80,000 bookings so far. The company said first-time buyers accounted for 48 per cent of the total bookings for the model.

For the nine months ended December 31, 2025, Hyundai Motor India reported EBITDA of Rs 6,632.5 crore, marking a year-on-year growth of 3.3 per cent.

EBITDA margins expanded to 12.8 per cent despite higher costs related to capacity stabilisation and commodity prices. Net profit for the nine-month period rose to Rs 4,175.9 crore.

Commenting on the results, Managing Director and CEO Tarun Garg said the company delivered healthy growth in volumes, revenue and profitability during the quarter.

He added that an improved sales mix and disciplined cost management helped support margins on a year-to-date basis.

Garg also highlighted strong sales in January 2026 as a positive sign for the rest of the financial year.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Vets to be legally required to publish price lists and cap prescription fees

Published

on

Vets to be legally required to publish price lists and cap prescription fees



Vets will be legally bound to prescription fee caps and publishing price lists among new measures which will start coming into force later this year, the competition watchdog has announced.

The Competition and Markets Authority (CMA) said its final reforms for the sector will help pet owners better navigate the vet services market.

Other legally binding measures will include a price comparison website and mandatory branding by the large groups to boost competition and drive down prices.

The CMA said pet owners using a vet practice that is part of a larger chain can expect to see changes before Christmas, including standard price lists.

The measures follow the CMA finding that fees have risen at almost twice the rate of inflation, with pet owners not being given enough information about their vet and the prices of treatments.

Martin Coleman, chairman of the independent Inquiry Group, said: “This is the most extensive review of veterinary services in a generation, and today’s reforms will make a real difference to the millions of pet owners who want the best for their pets but struggle to find the practice, treatment and price that meets their needs.

“Too often, people are left in the dark about who owns their practice, treatment options and prices – even when facing bills running into thousands of pounds.

“Our measures mean it will be made clear to pet owners which practices are part of large groups, which are charging higher prices, and for the first time, vet businesses will be held to account by an independent regulator.

“Our changes put pet owners at the centre but also help vets by enhancing trust in the profession and protecting clinical judgment from undue commercial pressure – and that is important to ensure our pets continue to get the best care.”

The CMA said practices must publish a comprehensive price list for standard services, including consultations, common procedures, diagnostics, written prescriptions and cremation options under its new rules.

Prescriptions – for which “many” practices charge £30 or more for each – are to be capped at £21 for the first medicine and £12.50 for any additional medicines.

Practices must also provide a written estimate in advance for any treatment expected to cost £500 or more, including aftercare costs, as well as an itemised bill.

Emergency care will be the only exception for written estimates.

Prices and information about who owns the surgery are to be made available to pet owners through the Royal College of Veterinary Surgeons (RCVS) ‘Find a Vet’ service, which will share the data with third-party comparison sites.

Vet businesses must make it clear whether they are part of a group or an independent business, with details of group ownership to be displayed on signs at the surgery and online.

British Veterinary Association president Rob Williams said: “The majority of the CMA’s measures focus on increasing transparency and information, which will help pet owners make more informed choices and support competition, which is a really positive step.”

He added: “Delivering highly skilled veterinary medicine is costly and whilst we recognise prices have risen sharply in recent years this is due to a number of factors, including the higher costs all businesses are experiencing – and vet practices are not immune.

“Plus, thanks to advances in diagnostics and medical technology over the last 20 years, vets can now do much more to manage disease and injury in animals, whereas in the past the only option available may have been to euthanase.

“Owners today also have a greater expectation of their vet, with many expecting human quality healthcare for their pets and whilst this is possible to deliver, it comes at a cost.”



Source link

Continue Reading

Business

Gold price prediction today: Pressure on gold prices to continue on March 24, 2026 amid US-Iran war? Check outlook – The Times of India

Published

on

Gold price prediction today: Pressure on gold prices to continue on March 24, 2026 amid US-Iran war? Check outlook – The Times of India



Gold price prediction today: Gold prices are likely to remain range-bound in the near future, says Praveen Singh, Head Currencies and Commodities, Mirae Asset ShareKhan



Source link

Continue Reading

Business

Estée Lauder is in talks to merge with Puig amid ongoing turnaround plan

Published

on

Estée Lauder is in talks to merge with Puig amid ongoing turnaround plan


An Estée Lauder pop-up store is seen inside a Daimaru store on Nanjing Road in Shanghai, China, Aug. 6, 2021.

Costfoto | Future Publishing | Getty Images

Estée Lauder Companies said Monday that it is in talks with Spanish beauty group Puig to potentially merge the two companies.

“No final decision has been made, and no agreement has been reached,” Estée Lauder said in a statement.

Shares of the U.S. beauty company were down nearly 8% following the news, which was first reported by the Financial Times. Puig’s stock rose roughly 3%.

Puig owns major beauty brands including Charlotte Tilbury, Jean Paul Gaultier and Rabanne. The companies did not disclose any financial details of the potential deal.

Estée Lauder has been struggling amid ongoing headwinds from tariffs and its restructuring as it enacts its “Beauty Reimagined” turnaround plan to revitalize the business. In its second-quarter earnings report last month, the beauty retailer said it’s expecting a $100 million hit to its full-year profitability due to tariff impacts.

Estée Lauder’s stock has dropped roughly 25% this year.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source link

Continue Reading

Trending